Study of GBR 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

2019-06-16 02:23:48 | BioPortfolio

Published on BioPortfolio: 2019-06-16T02:23:48-0400

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers

The purpose of this study is to determine the safety profile and maximum tolerable dose (MTD) of GBR 1302 monotherapy in subjects with HER2 positive cancers

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

The aim of the study is to assess prospectively the impact of radiosurgery on the quality of life in patients with brain metastases.

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

A Phase 1/2 Study of Carbon Ion Radiotherapy with Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).

This study evaluated the safety and efficacy of carbon-ion radiotherapy (C-ion RT) with concurrent chemotherapy (chemo-C-ion RT) for locally advanced uterine cervical squamous cell carcinoma in a phas...

Two-Dimensional Carbon-Based Auxetic Materials for Broad-Spectrum Metal-Ion Battery Anodes.

Auxetic materials possess special applications due to their unique negative Poisson's ratios (NPRs). As a classic two-dimensional (2D) carbon material, the NPR of graphene is still deliberated. Introd...

An institutional intervention to modify opioid prescribing practices after lumbar spine surgery.

OBJECTIVEPatients with lumbar spine pathology are at high risk for opioid misuse. Standardizing prescribing practices through an institutional intervention may reduce the overprescribing of opiates, l...

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "Study of GBR 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer"

Quick Search


Searches Linking to this Trial